From the Guidelines
Alpha blockers are a recommended treatment option for patients with bothersome, moderate to severe lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), including increased urinary frequency. According to the American Urological Association guideline 1, alpha blockers such as alfuzosin, doxazosin, silodosin, tamsulosin, or terazosin can be offered as a treatment option for these patients. These medications work by relaxing the smooth muscles in the prostate and bladder neck, which improves urine flow and reduces urinary frequency 1.
Key Points to Consider
- The choice of alpha blocker should be based on patient age and comorbidities, as well as different adverse event profiles, such as ejaculatory dysfunction and changes in blood pressure 1.
- Alpha blockers have been shown to be effective in reducing LUTS and improving quality of life in patients with BPH, with multiple phase III randomized control trials, phase IV studies, systematic reviews, and meta-analyses demonstrating their efficacy since the 1980s 1.
- Common side effects of alpha blockers include dizziness, headache, retrograde ejaculation, and orthostatic hypotension, especially when starting treatment 1.
- It is essential to start with a lower dose and gradually increase as needed to minimize side effects 1.
- Alpha blockers may be combined with 5-alpha reductase inhibitors for men with larger prostates for more comprehensive symptom management 1.
From the FDA Drug Label
The symptoms associated with benign prostatic hyperplasia (BPH), such as urinary frequency, nocturia, weak stream, hesitancy, and incomplete emptying are related to two components, anatomical (static) and functional (dynamic) The dynamic component of BPH is associated with an increase in smooth muscle tone in the prostate and bladder neck The degree of tone in this area is mediated by the alpha 1 adrenoceptor, which is present in high density in the prostatic stroma, prostatic capsule and bladder neck. Blockade of the alpha 1 receptor decreases urethral resistance and may relieve the obstruction and BPH symptoms and improve urine flow
Alpha blockers can help with increased urinary frequency related to BPH by blocking the alpha 1 receptor, which decreases urethral resistance and may relieve the obstruction and BPH symptoms, including urinary frequency, and improve urine flow 2.
- Key points:
- Alpha blockers decrease urethral resistance
- Relief of BPH symptoms, including urinary frequency
- Improvement of urine flow
- Main idea: Alpha blockers, such as doxazosin, can help alleviate BPH symptoms, including increased urinary frequency, by reducing urethral resistance and improving urine flow.
From the Research
Alpha Blockers and Urinary Frequency in BPH
- Alpha blockers are effective in managing benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) and improving the maximal urinary flow rate in short- and long-term treatment, regardless of prostate size 3.
- The use of alpha blockers can help reduce BPH-related symptoms, including increased urinary frequency 3, 4, 5.
- Studies have shown that alpha blockers, such as doxazosin, tamsulosin, and alfuzosin, are effective in relieving LUTS/BPH symptoms, including urinary frequency, with minimal side effects 4, 6.
- Combination therapy with an alpha blocker and a 5-alpha-reductase inhibitor (5ARI) may be beneficial in patients with more severe symptoms and larger prostate volume 3, 5.
Mechanism of Action
- Alpha blockers work by relaxing smooth muscle in the prostate, reducing outlet resistance, and improving bladder function, which can help alleviate urinary frequency and other LUTS symptoms 7.
- Alpha blockers may also have non-prostate effects, making them potentially useful in treating voiding dysfunction unrelated to BPH, including in women 7.
Efficacy and Safety
- Alpha blockers have been shown to be effective in reducing urinary frequency and other LUTS symptoms, with a low incidence of adverse effects, such as orthostatic hypotension 4, 6.
- However, some alpha blockers, such as tamsulosin, may cause abnormal ejaculation, which is a common adverse effect 4, 6.